Exenatide vs MOTS-c
Overview
Exenatide and MOTS-c are both weight management & metabolic peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares Exenatide and MOTS-c across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Exenatide | MOTS-c | |
|---|---|---|
| Category | Weight Management & Metabolic | Weight Management & Metabolic |
| Regulatory status (US) | FDA approved | Compounding (Rx) — Apr 2026 |
| Typical dosage | 5–10 mcg (Byetta) or 2 mg (Bydureon/Bydureon BCise) | 5-10 mg |
| Frequency | Twice daily (Byetta) or once weekly (Bydureon) | weekly |
| Reported benefits | Glycemic control (HbA1c reduction 0.8–1.9 percentage points), modest body weight reduction (2–4 kg), low intrinsic hypoglycemia risk, modest systolic blood pressure reduction, cardiovascular non-inferiority established in EXSCEL | Enhanced metabolism, improved insulin sensitivity, increased exercise capacity, longevity benefits |
| Reported side effects | Nausea, vomiting, diarrhea, injection site reactions, hypoglycemia (when co-administered with sulfonylureas), rare acute pancreatitis, rare acute kidney injury | Well-tolerated. Minimal reported side effects |
Key differences
Primary use. Exenatide is categorised under Weight Management & Metabolic, while MOTS-c falls under Weight Management & Metabolic. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. Exenatide: FDA-approved. MOTS-c: not FDA-approved; compounding permitted with a prescription as of April 2026.
Dosing. Exenatide is typically dosed at 5–10 mcg (Byetta) or 2 mg (Bydureon/Bydureon BCise) (Twice daily (Byetta) or once weekly (Bydureon)). MOTS-c is typically dosed at 5-10 mg (weekly).
Can you stack them?
Some protocols combine peptides, but stacking Exenatide and MOTS-c has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Exenatide and MOTS-c?
- Exenatide and MOTS-c are both weight management & metabolic peptides, but they differ in mechanism, dosing, and regulatory status. Exenatide is FDA-approved for one or more indications, whereas MOTS-c is not FDA-approved; compounding permitted with a prescription (as of April 2026).
- What is Exenatide used for?
- FDA-approved GLP-1 receptor agonist for type 2 diabetes; the first incretin mimetic approved in the US.
- What is MOTS-c used for?
- Mitochondrial optimization.
- Can you take Exenatide and MOTS-c together?
- Some users combine peptides within a single protocol, but stacking Exenatide and MOTS-c has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Exenatide or MOTS-c FDA-approved?
- Exenatide is FDA-approved for one or more indications. MOTS-c is not FDA-approved; compounding permitted with a prescription (as of April 2026).